Contract Research Organization Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Contract Research Organization stocks.

Contract Research Organization Stocks Recent News

Date Stock Title
Apr 24 ICLR ICON adjusts 2024 revenue, EPS guidance ranges
Apr 24 ICLR Icon PLC (ICLR) Beats Q1 Earnings and Revenue Estimates
Apr 24 ICLR ICON Non-GAAP EPS of $3.47 misses by $0.51, revenue of $2.09B in-line
Apr 24 ICLR ICON Reports First Quarter 2024 Results
Apr 24 MEDP Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2024 Earnings Call Transcript
Apr 24 ICLR Reason for the Surge of ICON Public Limited Company (ICLR)
Apr 24 MEDP Medpace Holdings, Inc. Just Beat EPS By 30%: Here's What Analysts Think Will Happen Next
Apr 24 MEDP Medpace Holdings Inc (MEDP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
Apr 24 MEDP Q1 2024 Medpace Holdings Inc Earnings Call
Apr 23 ICLR Icon Q1 2024 Earnings Preview
Apr 23 MEDP Medpace raised to Buy at Jefferies after Q1 earnings beat
Apr 23 MEDP Medpace Holdings, Inc. (MEDP) Q1 2024 Earnings Call Transcript
Apr 23 ICLR What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
Apr 23 MEDP Medpace Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation
Apr 22 MEDP Medpace Holdings Inc (MEDP) Surpasses Analyst Revenue and Earnings Projections in Q1 2024
Apr 22 MEDP Medpace GAAP EPS of $3.20 beats by $0.73, revenue of $511M misses by $1M
Apr 22 MEDP Medpace Holdings, Inc. Reports First Quarter 2024 Results
Apr 19 MEDP Medpace Q1 2024 Earnings Preview
Apr 18 ICLR ICON (ICLR) Gains From New Offerings, Strategic Acquisitions
Apr 18 ICLR Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
Contract Research Organization

A contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, clinical trials management, and pharmacovigilance. CROs are designed to reduce costs for companies developing new medicines and drugs in niche markets. They aim to simplify entry into drug markets, and simplify development, as the need for large pharmaceutical companies to do everything ‘in house’ is now redundant. CROs also support foundations, research institutions, and universities, in addition to governmental organizations (such as the NIH, EMA, etc.).Many CROs specifically provide clinical-study and clinical-trial support for drugs and/or medical devices. CROs range from large, international full-service organizations to small, niche specialty groups.
CROs that specialize in clinical-trials services can offer their clients the expertise of moving a new drug or device from its conception to FDA/EMA marketing approval, without the drug sponsor having to maintain a staff for these services.

Browse All Tags